Checkpoint Therapeutics, Inc.

General ticker "CKPT" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $126.3M (TTM average)

Checkpoint Therapeutics, Inc. follows the US Stock Market performance with the rate: 22.5%.

Estimated limits based on current volatility of 0.2%: low 4.15$, high 4.16$

Factors to consider:

  • Price in estimated range

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [2.45$, 6.86$]
  • 2025-12-31 to 2026-12-31 estimated range: [1.35$, 4.10$]

Financial Metrics affecting the CKPT estimates:

  • Negative: Non-GAAP EPS, $ of -1.43 <= 0.04
  • Negative: Operating cash flow per share per price, % of -16.82 <= 1.79
  • Negative: negative Operating income
  • Negative: negative Net income
  • Negative: Shareholder equity ratio, % of -168.99 <= 22.52
  • Negative: Industry operating cash flow per share per price (median), % of -21.10 <= 2.82
  • Negative: Industry earnings per price (median), % of -27.42 <= 0

Similar symbols

Short-term CKPT quotes

Long-term CKPT plot with estimates

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $0.19MM $0.10MM $0.04MM
Operating Expenses $58.52MM $52.25MM $56.22MM
Operating Income $-58.33MM $-52.15MM $-56.17MM
Non-Operating Income $-4.29MM $0.30MM $-0.07MM
Interest Expense $4.29MM $0.00MM $0.00MM
R&D Expense $49.83MM $43.57MM $36.15MM
Income(Loss) $-62.62MM $-51.85MM $-56.24MM
Profit(Loss)* $-66.92MM $-51.85MM $-56.24MM
Stockholders Equity $-19.48MM $-13.05MM $-12.62MM
Assets $13.29MM $5.38MM $7.47MM
Operating Cash Flow $-57.55MM $-47.59MM $-31.10MM
Financing Cash Flow $14.89MM $40.45MM $32.78MM
Earnings Per Share** $-7.57 $-2.77 $-1.42

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.